Share Twitter LinkedIn Facebook Email Alok Khorana, MD Of The Cleveland Clinic Discusses CASSINI Study Results: Reduction In Blood Clots When Taking Daily Rivaroxaban, No Increase In Bleeding.
SGNTUC-024 Phase 1b/2 study: Tucatinib, trastuzumab, FOLFOX for HER2+ GI cancers Gastrointestinal 8 Mins Read